Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

104.10
Delayed Data
As of Nov 17
 0.00 / 0.00%
Today’s Change
94.55
Today|||52-Week Range
147.17
-10.06%
Year-to-Date
Cancer Space Update: Label Expansion for Three Major Drugs
Nov 17 / Zacks.com - Paid Partner Content
Citizens Financial Group Inc Buys Celgene Corp, iShares MSCI EAFE, Vanguard S&P 500, ...
Nov 13 / GuruFocus News - Paid Partner Content
Celgene CAR-T Therapy Gets Breakthrough Therapy Designation
Nov 17 / Zacks.com - Paid Partner Content
Big-Cap Biotechs Are Dragging
Nov 13 / TheStreet.com - Paid Partner Content
Biotechs Trading Lower in Q4 on Macro Uncertainty, Tepid Q3
Nov 17 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Facebook, Celgene, BlackRock, Danaher and BP
Nov 07 / Zacks.com - Paid Partner Content
Stanley Druckenmiller Starts 3 Positions in 3rd Quarter
Nov 15 / GuruFocus News - Paid Partner Content
Top Stock Reports for Facebook, Celgene & BlackRock
Nov 06 / Zacks.com - Paid Partner Content
Trust Co Of Virginia Buys Dominion Energy Inc, iShares Cohen & Steers REIT, United ....
Nov 14 / GuruFocus News - Paid Partner Content
Celgene sales target cuts signal wider biotech blues
Oct 26 / FT.com - Paid Partner Content